Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cough Syrup Market, by Product
1.4.2 North America Cough Syrup Market, by Age Group
1.4.3 North America Cough Syrup Market, by Distribution Channel
1.4.4 North America Cough Syrup Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Cough Syrup Market
Chapter 4. North America Cough Syrup Market by Product
4.1 North America Cough Suppressants Market by Country
4.2 North America Combination Medications Market by Country
4.3 North America Expectorants Market by Country
Chapter 5. North America Cough Syrup Market by Age Group
5.1 North America Adult Market by Country
5.2 North America Pediatric Market by Country
Chapter 6. North America Cough Syrup Market by Distribution Channel
6.1 North America Retail Pharmacy Market by Country
6.2 North America Hospital Pharmacy Market by Country
6.3 North America Online Market by Country
Chapter 7. North America Cough Syrup Market by Country
7.1 US Cough Syrup Market
7.1.1 US Cough Syrup Market by Product
7.1.2 US Cough Syrup Market by Age Group
7.1.3 US Cough Syrup Market by Distribution Channel
7.2 Canada Cough Syrup Market
7.2.1 Canada Cough Syrup Market by Product
7.2.2 Canada Cough Syrup Market by Age Group
7.2.3 Canada Cough Syrup Market by Distribution Channel
7.3 Mexico Cough Syrup Market
7.3.1 Mexico Cough Syrup Market by Product
7.3.2 Mexico Cough Syrup Market by Age Group
7.3.3 Mexico Cough Syrup Market by Distribution Channel
7.4 Rest of North America Cough Syrup Market
7.4.1 Rest of North America Cough Syrup Market by Product
7.4.2 Rest of North America Cough Syrup Market by Age Group
7.4.3 Rest of North America Cough Syrup Market by Distribution Channel
Chapter 8. Company Profiles
8.1 Pfizer, Inc.
8.1.1 Company Overview
8.1.1 Financial Analysis
8.1.2 Regional Analysis
8.1.3 Research & Development Expense
8.1.4 Recent strategies and developments:
8.1.4.1 Acquisition and Mergers:
8.2 Novartis AG
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.3 Merck Group
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 Johnson and Johnson
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental &Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.5 GlaxoSmithKline PLC (GSK)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.6 The Procter and Gamble Company
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Acquisition and Mergers:
8.7 Reckitt Benckiser Group PLC
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.8 Abbott Laboratories
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 Sanofi S.A.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.10. Acella Pharmaceuticals, LLC (Alora Pharmaceuticals, LLC)
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Approvals:
Unique Offerings 
